Net profit of Jiangsu Hengrui Pharmaceuticals 2015-2022

Published by
Wenyi Zhang,
Aug 14, 2023
In 2022, the Chinese firm Jiangsu Hengrui Pharmaceuticals generated a net profit of around 3.8 billion yuan, indicating a downward trend after the steady growth before 2020. The core products of Jiangsu Hengrui Medicine include anti-tumor medicines, pain-killers, and anti-infection medicines.

Annual net profit of Jiangsu Hengrui Pharmaceuticals Co., Ltd. from 2015 to 2022 (in billion yuan)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

April 2023

Region

China

Survey time period

2015 to 2022

Supplementary notes

One yuan equals approximately 0.14 U.S. dollars and 0.13 euros (as of August 2023).

Figures prior to 2021 have been retrieved from the previous publications.
Figures have been rounded for a better understanding.

Citation formats
Access all statistics starting from $1,788 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$149 USD $199 USD
per month, billed annually 1
Buy now
25% off until Sep 30th
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Jiangsu Hengrui Pharmaceuticals "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Jiangsu Hengrui Pharmaceuticals

Company positioning

6

Key company data

8

Research and development

5

Competitors

5

The oncology drug market

4

Further Content: You might find this interesting as well

Topics

Hengrui PharmaceuticalsMedical technology in ChinaPfizerJohnson & JohnsonPharmaceutical industry in Japan
Access all statistics starting from $1,788 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$149 USD $199 USD
per month, billed annually 1
Buy now
25% off until Sep 30th
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu